Stockscreener 앱 받기
0.5998
2.09%
-0.0128
전일 마감가:
$0.6126
열려 있는:
$0.6068
하루 거래량:
217.74K
Relative Volume:
0.20
시가총액:
$55.16M
수익:
$11.03M
순이익/손실:
$-44.24M
주가수익비율:
-0.9674
EPS:
-0.62
순현금흐름:
$-42.61M
1주 성능:
-16.60%
1개월 성능:
-14.23%
6개월 성능:
-32.22%
1년 성능:
-31.06%
1일 변동 폭
$0.5924
$0.6068
1주일 범위
$0.5924
$0.8021
52주 변동 폭
$0.5837
$1.90
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
HYPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.5998 | 55.16M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
132.57 | 233.05B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.80 | 155.05B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
392.12 | 146.77B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.41 | 106.66B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.59 | 44.02B | 5.54B | 4.18B | 623.10M | 7.00 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | 개시 | Evercore ISI | Outperform |
| 2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
B. Riley Reduces Price Target for Hyperfine (HYPR) After Sales M - GuruFocus
B. Riley Lowers Price Target on Hyperfine to $1 From $1.20, Keeps Buy Rating - marketscreener.com
Hyperfine Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Lags Revenue Estimates - MSN
Wells Fargo Updates Price Target and Rating for HYPR | HYPR Stoc - GuruFocus
Hyperfine (HYPR) Reports Lower Q1 Revenue, Optimistic About Futu - GuruFocus
Hyperfine, Inc. (NASDAQ:HYPR) Q1 2025 Earnings Call Transcript - Insider Monkey
Hyperfine’s net loss for Q1 2025 hits USD 9.4M - Medical Buyer
Hyperfine outlines 10%–20% revenue growth for 2025 as new product launches and office market entry drive diversification - MSN
Hyperfine Q1 2025 Earnings Call Transcript - MarketBeat
Hyperfine, Inc. Reports Q1 2025 Financial Results - TipRanks
Hyperfine reports Q1 EPS (12c), consensus (12c) - TipRanks
Earnings call transcript: Hyperfine Misses Q1 2025 Revenue Expectations By Investing.com - Investing.com India
Earnings call transcript: Hyperfine Misses Q1 2025 Revenue Expectations - Investing.com
Hyperfine Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Hyperfine Q1 2025 slides reveal portable MRI expansion strategy despite mixed results - Investing.com Australia
Hyperfine Q1 2025 slides reveal portable MRI expansion strategy despite mixed results By Investing.com - Investing.com South Africa
Hyperfine Inc (HYPR) Q1 2025 Earnings: EPS Meets Estimate at -$0 - GuruFocus
Hyperfine Inc Files For Offering Of Up To $50 Million Of Shares Of Class A Common Stock - marketscreener.com
Hyperfine, Inc. SEC 10-Q Report - TradingView
Hyperfine, Inc. Reports First Quarter 2025 Financial Results - The Manila Times
Hyperfine Inc (HYPR) Q1 2025 Earnings Report Preview: What To Lo - GuruFocus
Chipiron building ultra-low portable MRI scanner following $17M raise - BioWorld MedTech
Hyperfine (HYPR) Projected to Post Quarterly Earnings on Tuesday - Defense World
Renaissance Technologies LLC Boosts Stock Holdings in Hyperfine, Inc. (NASDAQ:HYPR) - Defense World
Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025 - Business Wire
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices - 01net
Hyperfine Enrolls First Patients in Portable MRI Evaluation Study - marketscreener.com
Hyperfine enrolls initial patients in NEURO PMR study - TipRanks
Revolutionary Portable MRI Secures Medicare Coverage as Major Clinical Trial Launches - Stock Titan
Hyperfine (NASDAQ:HYPR) Stock Price Up 0.5% – Should You Buy? - Defense World
HYPR Stock Price and Chart — NASDAQ:HYPR - TradingView
HYPR stock touches 52-week low at $0.76 amid market challenges - Investing.com
Lake Street Initiates Coverage of Hyperfine (HYPR) with Buy Recommendation - MSN
Lake Street starts Hyperfine stock with Buy, sets $1.50 target By Investing.com - Investing.com Australia
Lake Street starts Hyperfine stock with Buy, sets $1.50 target - Investing.com
Lake Street Initiates Hyperfine at Buy With $1.50 Price Target -March 24, 2025 at 08:20 am EDT - MarketScreener
Hyperfine initiated with a Buy at Lake Street - TipRanks
What You Can Learn From Hyperfine, Inc.'s (NASDAQ:HYPR) P/S After Its 28% Share Price Crash - Simply Wall St
Hyperfine price target lowered to $1.20 from $1.50 at B. Riley - TipRanks
B. Riley Trims Price Target on Hyperfine to $1.20 From $1.50, Keeps Buy Rating -March 20, 2025 at 07:57 am EDT - Marketscreener.com
Hyperfine Inc (NASDAQ: HYPR) Fell -6.75%, Now What? Don’t Panic - Stocksregister
Hyperfine, Inc. (NASDAQ:HYPR) Q4 2024 Earnings Call Transcript - Insider Monkey
Hyperfine Inc. Faces Potential Stock Price Decline Amid $150 Million Securities Sale Plan - TipRanks
Hyperfine Inc. Earnings Call: Growth Amid Challenges - TipRanks
Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating By Investing.com - Investing.com South Africa
Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating - Investing.com
HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging - Nasdaq
Hyperfine teams up with NVIDIA to enhance AI-powered portable MR - DOTmed HealthCare Business News
Hyperfine reports net loss of USD 10.39M in Q4 2024 - Medical Buyer
Hyperfine Inc (HYPR) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges By GuruFocus - Investing.com Canada
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Hyperfine Inc 주식 (HYPR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| TEISSEYRE THOMAS | Chief Operating Officer |
Nov 18 '24 |
Sale |
0.85 |
2,800 |
2,380 |
88,227 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Aug 16 '24 |
Sale |
1.05 |
2,746 |
2,883 |
91,027 |
| TEISSEYRE THOMAS | Chief Operating Officer |
May 16 '24 |
Sale |
0.88 |
2,753 |
2,423 |
93,773 |
1.07%
0.97%
자본화:
|
볼륨(24시간):